New generation bioresorbable scaffold technologies: An update on novel devices and clinical results

D Regazzoli, PP Leone, A Colombo, A Latib

Research output: Contribution to journalArticle

Abstract

Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.
Original languageEnglish
Pages (from-to)S979-S985
JournalJournal of Thoracic Disease
Volume9
Issue number2
Publication statusPublished - 2017

Fingerprint

Thoracic Diseases
Drug-Eluting Stents
Cardiology
Thrombosis
Technology
Equipment and Supplies
Incidence

Cite this

New generation bioresorbable scaffold technologies: An update on novel devices and clinical results. / Regazzoli, D; Leone, PP; Colombo, A; Latib, A.

In: Journal of Thoracic Disease, Vol. 9, No. 2, 2017, p. S979-S985.

Research output: Contribution to journalArticle

Regazzoli, D, Leone, PP, Colombo, A & Latib, A 2017, 'New generation bioresorbable scaffold technologies: An update on novel devices and clinical results', Journal of Thoracic Disease, vol. 9, no. 2, pp. S979-S985.
Regazzoli, D ; Leone, PP ; Colombo, A ; Latib, A. / New generation bioresorbable scaffold technologies: An update on novel devices and clinical results. In: Journal of Thoracic Disease. 2017 ; Vol. 9, No. 2. pp. S979-S985.
@article{8062059454634772a6234d0ce1c3c15f,
title = "New generation bioresorbable scaffold technologies: An update on novel devices and clinical results",
abstract = "Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. {\circledC} Journal of Thoracic Disease.",
author = "D Regazzoli and PP Leone and A Colombo and A Latib",
year = "2017",
language = "English",
volume = "9",
pages = "S979--S985",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "AME Publishing Company",
number = "2",

}

TY - JOUR

T1 - New generation bioresorbable scaffold technologies: An update on novel devices and clinical results

AU - Regazzoli, D

AU - Leone, PP

AU - Colombo, A

AU - Latib, A

PY - 2017

Y1 - 2017

N2 - Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.

AB - Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development. © Journal of Thoracic Disease.

M3 - Article

VL - 9

SP - S979-S985

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 2

ER -